WallStreetZenWallStreetZen

NASDAQ: RLAY
Relay Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RLAY past revenue growth

How has RLAY's revenue growth performed historically?
Company
1,749.82%
Industry
144.63%
Market
17.55%
RLAY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RLAY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RLAY's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RLAY earnings and revenue history

Current Revenue
$25.5M
Current Earnings
-$342.0M
Current Profit Margin
-1,338.7%

RLAY Return on Equity

Current Company
-42.4%
Current Industry
-63.5%
Current Market
188%
RLAY's Return on Equity (-42.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RLAY announces earnings.

RLAY Return on Assets

Current Company
-36.5%
Current Industry
2.9%
RLAY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RLAY Return on Capital Employed

Current Company
-42.03%
Current Industry
19.5%
RLAY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RLAY vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RLAY$25.55M-$336.70M-$341.97M-88.41%N/A
EYPT$46.02M-$69.00M-$70.80M+58.70%N/A
ALXO$0.00-$158.40M-$160.81M-100.00%N/A
SAGE$91.06M-$501.74M-$503.14M+0.07%N/A
IMTX$58.69M-$97.57M-$105.43M+69.15%N/A
View Top Biotech Stocks

RLAY earnings dates

Next earnings date
Jun 3, 2024

Relay Therapeutics Earnings & Revenue FAQ

What were RLAY's earnings last quarter?

On Invalid Date, Relay Therapeutics (NASDAQ: RLAY) reported Q4 2023 earnings per share (EPS) of -$0.67, up 21.82% year over year. Total Relay Therapeutics earnings for the quarter were -$83.50 million. In the same quarter last year, Relay Therapeutics's earnings per share (EPS) was -$0.55.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.

What was RLAY's earnings growth in the past year?

As of Q2 2024, Relay Therapeutics's earnings has grown year over year. Relay Therapeutics's earnings in the past year totalled -$341.97 million.

What is RLAY's earnings date?

Relay Therapeutics's earnings date is Invalid Date. Add RLAY to your watchlist to be reminded of RLAY's next earnings announcement.

What was RLAY's revenue last quarter?

On Invalid Date, Relay Therapeutics (NASDAQ: RLAY) reported Q4 2023 revenue of -$1.00 thousand up 100.4% year over year. In the same quarter last year, Relay Therapeutics's revenue was $253.00 thousand.

What was RLAY's revenue growth in the past year?

As of Q2 2024, Relay Therapeutics's revenue has grown 1,749.82% year over year. This is 1,605.19 percentage points higher than the US Biotechnology industry revenue growth rate of 144.63%. Relay Therapeutics's revenue in the past year totalled $25.55 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.